⚠️ This is general awareness information, not medical advice and not advertising. It does not recommend any medicine, brand, dose, or supplier. These are prescription-only medicines — whether one is right for you is a decision only your doctor can make with you. Information checked against official sources in June 2026; eligibility rules and prices change, so always confirm current details via the official links below.

GLP-1 receptor agonists are a class of prescription medicines used in Australia for type 2 diabetes and, separately, for weight management. You may have heard them referred to by brand names. They are Schedule 4 (prescription-only) medicines, so they can only be supplied on a valid prescription from an Australian-registered prescriber. This page explains the system around them — cost, access and safety — so you can have an informed conversation with your GP. It does not tell you whether to take one.

💡 Looking for the specifics? If you want to see the actual products available in Australia (Ozempic, Mounjaro, Wegovy, Trulicity) compared side-by-side — TGA indication, PBS status, cost — see the GLP-1 medicines in Australia guide.

💰 Cost & the PBS — the general picture–

What you pay depends heavily on why the medicine is prescribed:

On the PBS, these medicines are subsidised only for specific medical conditions that meet set criteria (for example, type 2 diabetes) — not for general weight loss.
When a medicine is prescribed outside a subsidised condition (including most weight-management use), it is usually a private prescription paid in full, which can be substantially more expensive.
Prices and which products are listed change over time. Always check the current listing rather than relying on a figure you read somewhere.

Check current PBS listings and criteria at pbs.gov.au. Your GP and pharmacist can tell you what applies to your situation and what it will actually cost you.

🛡️ Safety: compounded & online "copycat" products–

The Therapeutic Goods Administration (TGA) has warned the public about compounded and unapproved "semaglutide-like" products sold online and by some clinics. These are not the same as TGA-approved medicines:

They have not been assessed by the TGA for safety, quality, or effectiveness.
Dose accuracy and ingredients can be uncertain, and serious dosing errors have been reported.
Buying prescription medicines from overseas or unverified online sellers carries real safety and legal risks.

The safest path is a genuine, TGA-approved product dispensed by an Australian pharmacy against a valid prescription. Read the TGA's consumer information at tga.gov.au.

📦 Supply & shortages–

Supply of some of these medicines has been limited at times, which can affect availability and prescribing. Shortages and their expected resolution dates change frequently.

Check the current status on the TGA Medicine Shortage Reports Database via tga.gov.au, and ask your pharmacist about local availability.

🚚 Home-delivery platforms (LillyDirect)–

In September 2026, Eli Lilly Australia launched LillyDirect, an online platform for prescribed Lilly medicines. Mounjaro (tirzepatide) is the first medicine on it.

It needs an e-script from your doctor. Prescribing decisions and clinical responsibility stay with your doctor.
The e-script is sent to a licensed Australian pharmacy, which dispenses the medicine and delivers it to your home. LillyDirect itself is not a pharmacy.
Lilly says delivery is included in the price and that prices are shown after the e-script is entered. The terms of Evermed, which runs the platform, list delivery costs separately from the product price, so check the total shown before you pay. Lilly has said a click-and-collect option from local pharmacies will follow.
Evermed’s terms say it does not dispense medicines (registered community pharmacies do), that temperature-sensitive medicines may be left unattended if nobody is home, and that keeping them in suitable conditions after delivery is the customer’s responsibility.
The terms also say you must be 16 or over to order and that returns are not accepted for change of mind (your Australian Consumer Law rights still apply).

The RACGP, the Pharmacy Guild of Australia and the Pharmaceutical Society of Australia have raised concerns about the model, including fewer opportunities for face-to-face checks and for a pharmacist to see a person’s full medicines list. Lilly says an Australian pharmacist reviews and dispenses every prescription and is available to advise.

This page does not recommend any supplier. Your doctor and pharmacist can explain your options.

Sources: Lilly Australia, LillyDirect; RACGP newsGP, 22 Sep 2026; ABC News, 1 Oct 2026; Evermed terms and conditions (shown as a pop-up when signed in to the LillyDirect platform).

🩺 What to ask your GP–

If you're wondering whether one of these medicines could be relevant to you, a GP visit is the right next step. Questions you might bring:

Given my health history, is a medicine like this clinically appropriate for me?
Would I be eligible for any PBS subsidy, or would this be a private prescription?
What would it realistically cost me, and for how long?
What are the risks, side effects, and monitoring involved?
What non-medication options should I consider alongside or instead?

Your GP knows your full history and circumstances — their advice always takes priority over general information like this.

👩‍⚕️ For clinicians: see the GLP-1 prescribing reference — PBS access, the Authority process, and cost.

This page is general health information, not medical advice, and is not promotion of any medicine. It does not recommend, rank, or tell you how to obtain any product. Decisions about prescription medicines must be made with a qualified healthcare professional who knows your individual circumstances.

📋 Sources: Pharmaceutical Benefits Scheme (pbs.gov.au), Therapeutic Goods Administration (tga.gov.au), and Healthdirect (healthdirect.gov.au). General information verified June 2026 — confirm current details via these official sources.

GLP-1 injections in Australia: cost, access & safety